Industrial Purity Specifications for 2,2'-Dibromodiethyl Ether
- Target GC assay purity exceeds 98% for optimal reaction yields in organic synthesis.
- Strict moisture control below 0.3% prevents hydrolysis during storage and handling.
- Bulk procurement strategies reduce unit costs significantly compared to laboratory-grade packaging.
In the realm of fine chemical synthesis, the reliability of halogenated ether intermediates dictates the success of downstream pharmaceutical and material science applications. 2,2'-Dibromodiethyl ether (CAS: 5414-19-7) serves as a critical building block for constructing complex heterocyclic systems and polymeric networks. For process chemists and procurement managers, understanding the nuanced specifications of this compound is essential for maintaining consistent reaction yields and minimizing purification burdens. This technical overview details the quality metrics, synthesis methodologies, and commercial considerations required for industrial-scale adoption.
Key Quality Metrics for Industrial-Grade Material
When evaluating suppliers, the Certificate of Analysis (COA) is the primary document for verifying material suitability. For high-performance applications, industrial purity standards typically demand a Gas Chromatography (GC) assay of ≥98.0%. Lower grades, often found in general laboratory catalogs, may hover around 90-95%, which can introduce significant impurities such as mono-brominated analogs or residual solvents that interfere with nucleophilic substitution reactions.
Moisture content is another critical parameter. As an alkylating agent, this ether is susceptible to hydrolysis if water content exceeds 0.3%. Elevated moisture levels can lead to the formation of diethylene glycol during storage, reducing the effective concentration of the active bromine species. A comprehensive COA should also specify the refractive index (typically around 1.513) and density (1.845 g/mL at 25 °C) to confirm identity and bulk consistency. Visual inspection should reveal a colorless to light yellow liquid; darkening often indicates decomposition or oxidation.
Optimizing the Synthesis Route for Yield and Purity
The standard synthesis route for producing this dibrominated ether involves the bromination of diethylene glycol. A common manufacturing process utilizes phosphorus tribromide (PBr3) as the brominating agent in an inert solvent such as carbon tetrachloride or ethyl acetate. The reaction is highly exothermic and requires precise temperature control, typically maintained between 0 °C and room temperature during the addition phase.
To achieve high purity, the manufacturing process must include rigorous workup procedures. After the reaction reaches completion, usually over 15 hours of stirring, the solvent is removed under reduced pressure. The residue is then dissolved in ethyl acetate and washed multiple times with aqueous sodium carbonate to neutralize residual acid. Final distillation under vacuum is necessary to isolate the target product, ensuring the removal of high-boiling impurities and unreacted glycol. Optimizing this sequence is vital for maximizing yield, which can reach approximately 80-85% under ideal conditions. When sourcing high-purity 1-bromo-2-(2-bromoethoxy)ethane, buyers should verify that the supplier employs fractional distillation to meet stringent GC specifications.
Commercial Specifications and Bulk Procurement
Pricing structures for halogenated ethers vary significantly based on volume and purity grades. Laboratory-scale packaging (5g to 50mL) often commands a premium bulk price per kilogram due to packaging and handling costs. In contrast, industrial procurement involving drum or tote quantities offers substantial cost efficiencies. Market data indicates that technical grade material (≥95%) is available at lower price points, but pharmaceutical-grade intermediates require tighter controls and command higher valuations.
Supply chain stability is another factor for large-scale production. A reliable global manufacturer ensures consistent batch-to-batch quality, which is crucial for regulatory filings and process validation. NINGBO INNO PHARMCHEM CO.,LTD. specializes in providing these technical advantages and bulk supply capabilities, ensuring that clients receive material that meets exacting synthetic requirements without the variability often seen in smaller trading companies.
Typical Industrial Specifications Table
| Parameter | Specification | Test Method |
|---|---|---|
| Appearance | Colorless to Light Yellow Liquid | Visual |
| Purity (GC) | ≥ 98.0% | Gas Chromatography |
| Moisture Content | ≤ 0.3% | Karl Fischer |
| Density (25 °C) | 1.845 g/mL | ASTM D4052 |
| Refractive Index | 1.513 | ASTM D1218 |
| Boiling Point | 92-93 °C (12 mm Hg) | Distillation |
Safety, Stability, and Storage Protocols
Handling 2,2'-Dibromodiethyl ether requires strict adherence to safety protocols due to its hazardous nature. The compound is classified under GHS05 and GHS07, with hazard statements indicating it causes skin irritation, serious eye damage, and may cause respiratory irritation (H315, H318, H335). It is combustible and incompatible with strong oxidizing agents, acid chlorides, and reducing agents. Proper Personal Protective Equipment (PPE), including eyeshields, gloves, and type ABEK respirator filters, is mandatory during handling.
For long-term stability, the material should be stored in tightly closed containers within a dry, ventilated area. The recommended storage temperature is between 2-8°C to minimize decomposition. Under these conditions, the product remains stable, though users should consult SDS data for potential contaminants like 2-chloroethyl ether or DMF that may arise from specific synthesis pathways. Transport classifications typically list this substance under UN 2810 or UN 3334, Hazard Class 6.1, Packing Group III.
Conclusion
Selecting the right grade of Ethane 1,1'-oxybis[2-bromo- derivative is fundamental to the efficiency of organic synthesis workflows. By prioritizing high GC assay values, low moisture content, and verified synthesis routes, manufacturers can ensure robust reaction performance. Partnering with an established entity like NINGBO INNO PHARMCHEM CO.,LTD. provides access to consistent quality and competitive industrial pricing, securing the supply chain for critical intermediate production.